These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 33276471)

  • 1. Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator.
    Sheeler C; Rosa JG; Ferro A; McAdams B; Borgenheimer E; Cvetanovic M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are activated and reactive glia and what is their role in neurodegeneration?
    Bennett ML; Viaene AN
    Neurobiol Dis; 2021 Jan; 148():105172. PubMed ID: 33171230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes and microglia: responses to neuropathological conditions.
    Singh S; Swarnkar S; Goswami P; Nath C
    Int J Neurosci; 2011 Nov; 121(11):589-97. PubMed ID: 21827229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal Functions in Glia Associated with Neurodegeneration.
    Kreher C; Favret J; Maulik M; Shin D
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient IKK2 activation in astrocytes initiates selective non-cell-autonomous neurodegeneration.
    Lattke M; Reichel SN; Magnutzki A; Abaei A; Rasche V; Walther P; Calado DP; Ferger B; Wirth T; Baumann B
    Mol Neurodegener; 2017 Feb; 12(1):16. PubMed ID: 28193238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human iPSC-derived glia models for the study of neuroinflammation.
    Stöberl N; Maguire E; Salis E; Shaw B; Hall-Roberts H
    J Neuroinflammation; 2023 Oct; 20(1):231. PubMed ID: 37817184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting innate immunity for neurodegenerative disorders of the central nervous system.
    Andreasson KI; Bachstetter AD; Colonna M; Ginhoux F; Holmes C; Lamb B; Landreth G; Lee DC; Low D; Lynch MA; Monsonego A; O'Banion MK; Pekny M; Puschmann T; Russek-Blum N; Sandusky LA; Selenica ML; Takata K; Teeling J; Town T; Van Eldik LJ
    J Neurochem; 2016 Sep; 138(5):653-93. PubMed ID: 27248001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide.
    Villa V; Thellung S; Bajetto A; Gatta E; Robello M; Novelli F; Tasso B; Tonelli M; Florio T
    Pharmacol Res; 2016 Nov; 113(Pt A):500-514. PubMed ID: 27667770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia in Neurodegenerative Events-An Initiator or a Significant Other?
    Harry GJ
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Neurological Disorders with Human Pluripotent Stem Cell-Derived Astrocytes.
    Suga M; Kondo T; Inoue H
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases.
    Afridi R; Rahman MH; Suk K
    Neurobiol Dis; 2022 Nov; 174():105874. PubMed ID: 36154877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms.
    Oksanen M; Lehtonen S; Jaronen M; Goldsteins G; Hämäläinen RH; Koistinaho J
    Cell Mol Life Sci; 2019 Jul; 76(14):2739-2760. PubMed ID: 31016348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models.
    Rõlova T; Lehtonen Š; Goldsteins G; Kettunen P; Koistinaho J
    Stem Cells; 2021 Mar; 39(3):256-265. PubMed ID: 33270954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
    Kwon HS; Koh SH
    Transl Neurodegener; 2020 Nov; 9(1):42. PubMed ID: 33239064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia-Specific Metabolic Changes in Neurodegeneration.
    Aldana BI
    J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial phagocytic clearance in Parkinson's disease.
    Tremblay ME; Cookson MR; Civiero L
    Mol Neurodegener; 2019 Apr; 14(1):16. PubMed ID: 30953527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders.
    Jha MK; Lee WH; Suk K
    Biochem Pharmacol; 2016 Mar; 103():1-16. PubMed ID: 26556658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells.
    Tcw J; Wang M; Pimenova AA; Bowles KR; Hartley BJ; Lacin E; Machlovi SI; Abdelaal R; Karch CM; Phatnani H; Slesinger PA; Zhang B; Goate AM; Brennand KJ
    Stem Cell Reports; 2017 Aug; 9(2):600-614. PubMed ID: 28757165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinflammation: Integrated Nervous Tissue Response through Intercellular Interactions at the "Whole System" Scale.
    Nosi D; Lana D; Giovannini MG; Delfino G; Zecchi-Orlandini S
    Cells; 2021 May; 10(5):. PubMed ID: 34068375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.